USP32 and colonic neoplasm: Moreover, Kaplan-Meier analysis of TCGA survival data indicated that elevated expression of USP32 and PD-L1 correlates with worse survival in colon cancer patients (Figure 5O), indicating that high USP32 expression may be associated with an adverse prognosis in colon cancers.